Medical Marijuana Genetics

Medical Marijuana Genetics

Coffee Shop Seeds offers you great value with the best quality cannabis seeds, marijuana seeds, and CBD.

We are passionate about cannabis. Legalization of cannabis across the world would give medicinal users access to the strains that suit their condition and recreational users would enjoy better control, higher quality, and more safety.

For now, for that safe and secure feeling, you can’t beat our discrete service and our commitment to quality. We don’t just aim to please; we will exceed your expectations or fall over trying.

We’ve found that exceeding expectations gets easier when you have an awesome product range to back you up. Our 3500+ supply now includes the work of more than 120 world-renowned breeders, giving you thousands of strain choices.

Whether you’re looking for high THC/CBD or high yield, a particular flavor or a specific feeling, classic or cutting-edge, we offer you strains to suit your individual needs and desires.

Medical Marijuana Genetics first learnt of the therapeutic properties of the cannabis plant in 2014. Whilst desperately treating the symptoms of one of the founders mother’s late stage pancreatic cancer. Not long after her first dose of cannabis oil, she was able to move around relatively pain free. This enabled her to tend to her beloved garden, in the weeks leading up to her death.

Medical Marijuana Genetics teamed with award winning breeders from Spain, with the initial aim of creating a line of CBD dominant cannabis strains. Using genetics from a number of well established strains, Medical Marijuana Genetics successfully created Candida (CD-1). Aptly named after the founder’s mother and meaning ‘bright light’ in Latin.

Medical Marijuana Genetics have had results ranging from 20.65% CBD with 0.7% THC to 10.65% CBD to 0.39% THC. These percentages represent the highest known consistent ratios in a CBD-rich seed strain ever created in Europe.

Medical Marijuana Genetics created a further 12 elite strains using Candida as a parent. They have selected their favourite’s of these to release alongside their flagship Candida strain. These have been selected to provide access (within lawful jurisdiction) to the widest range of therapeutics that the cannabis plant, and CBD in particular, has to offer. This includes treatments for symptoms such chronic pain, inflammation, seizures, convulsions, gastro-intestinal disorders, nausea, vomiting, skin conditions, bacterial infections, anxiety, depression, cancer cell growth and much more. All of the strains that are being launched are CBD dominant and have a CBD content of over 8%, but some strains veer towards a 1:1 ratio.

In 2017 MMG strains won 5 Spannabis Champions Cups in Barcelona and Madrid. The awards include a 1st (BCN), 2nd and 3rd place (MAD)  in CBD categories for Orinoco OR1, Candida CD1 and Nightingale NN1 and a 2nd and 3rd in the Indica category for as yet unreleased genetics.

Show Filters

Showing the single result

Showing the single result